Here's why these 4 stocks smashed the market today

Financial services stocks with global exposure like Platinum Asset Management Limited (ASX:PTM) and Magellan Financial Group Ltd (ASX:MFG) continue to outperform.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P / ASX 200 (Index: ^AXJO) (ASX: XJO) has again drifted sideways today as the market lacks direction before the arrival of February's half-year reporting season. However, there are several stocks bucking the trend to fly higher on the back of brightening outlooks.

Macquarie Group Ltd (ASX: MQG) yesterday announced it expects full year profit growth to be up 10-20% over the prior year. In response the stock has lifted 2.66% today to close at $59.80 and still looks to be trading on a reasonable valuation with an attractive yield. The bank will provide more detail on its position during an operational briefing scheduled for February 17, and if markets remain reasonable I expect it will perform well in 2015.

Platinum Asset Management Limited (ASX: PTM) is a global equities manager that has climbed 3.67% today and around 13% over the prior month. The group announced a modest growth in funds under management (FUM) for December 2014 recently, but the investor support is probably linked to Platinum's international exposure.

With the Australian economy expected to underperform versus international peers in the year ahead, investors are likely betting on an upturn in demand for international equity exposure from retail and institutional investors.

Magellan Financial Group Ltd (ASX: MFG) is another international equities manager that has outperformed Platinum recently as investors bet on growing demand for international equities exposure. The stock has soared around 60% over the past year, largely on the back of strong FUM growth. Up almost 3% to $18.03 today it will need to see post some strong FUM growth to justify its current valuation.

Somnomed Limited (ASX: SOM) is a healthcare stock that has simply shot the lights out over the last year to almost double in value at today's closing price of $3.10. The stock climbed 3.33% today as its momentum builds following strong recent sales numbers for its mouthguard-like sleep apnea treatment device.

The company has been investing heavily in its US business, although sales elsewhere in the world are now beginning to show positive signs. The business is on a big valuation, but may have a big future to match.

Motley Fool contributor Tom Richardson owns shares in Macquarie and Magellan. You can find him on Twitter @tommyr345

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »